BioSpace News Archive

The U.S. Senate rejected the Born-Alive Abortion Survivors Protection Act and Pain-Capable Unborn Child Protection Act, despite the best efforts of Senate Majority Leader Mitch McConnell and other pro-life leaders.

Securecell is proud to announce the partnership with Alit Life Science, Biofors Global and Danyel Biotech to build its market presence in China, Korea and Israel as a major step to further penetrate new markets.

ProBioGen AG today announced that ImmunOs Therapeutics AG has signed a Manufacturing Services Agreement for their novel platform of multitasking biologics. ProBioGen will support ImmunOs in the development of their biologics using its recently launched DirectedLuck Transposase technology and conducting large scale GMP manufacturing.

Domainex Ltd., a fully integrated provider of drug discovery services from its Medicines Research Centre near Cambridge, UK, has entered into a research partnership with LUNAC Therapeutics Limited to discover novel anticoagulant therapies that have a reduced risk of bleeding compared to current therapies.

Reduced stress is linked to changes in the profile of plasma metabolites, a new study from the University of Eastern Finland shows. According to the researchers, the findings can shed light on the associations of psychological well-being with metabolism and the risk of disease. The study was published in Scientific Reports.

Amarin Corporation plc, announced financial results for the quarter and year ended December 31, 2019 and provided an update on company operations.

Vanda Pharmaceuticals Inc. announced financial and operational results for the fourth quarter and full year ended December 31, 2019.

Evolent Health, Inc., a health care company that delivers proven clinical and administrative solutions to payers and providers, announced financial results for the quarter and full year ended December 31, 2019.

Jazz Pharmaceuticals plc announced financial results for the full year and the fourth quarter of 2019 and provided financial guidance for 2020.

Ironwood Pharmaceuticals, Inc. will present corporate updates at two upcoming investor conferences in March